Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIB-01 in Erectile Dysfunction
NCT06703840Phase 2Completed
- Sponsor
- Dicot Pharma AB
- Start
- Nov 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of LIB-01 in erectile dysfunction (ED), sponsored by Dicot Pharma AB. Started Nov 2024; status: completed.
02
Drugs
LIB-01
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06703840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06703840.